Why are pharma stocks down today? Here’s why Trump’s executive orders spark sell-off The pharma stocks in India see significant selloff after US President Donald Trump signs executive orders promoting active and faster… Updated: May 6, 2025 12:47 IST
Nomura’s top pharma bets include Dr. Reddy’s, Cipla, Lupin and Zydus Nomura recommends Buy for Dr. Reddy’s, Cipla, Lupin, Zydus amid pharma stock pressure. Check latest market trends! May 2, 2025 16:05 IST
Stocks to watch: From Macrotech Developers, Vedanta to Reliance Industries, Here’s a list of 10 stocks in news today Stocks to watch today, April 15: Explore the latest stock alerts: Macrotech, Reliance, Vedanta, Dr Reddy’s, and more. Check out… April 15, 2025 06:33 IST
Dr Reddy’s may cut workforce by 25%, including those in Rs 1 crore bracket: Report Dr Reddy’s may cut 25% of its workforce, including high earners, amid cost-cutting. Learn more! Updated: April 14, 2025 20:12 IST
Three reasons why pharma stocks are falling today? Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector. Updated: March 25, 2025 14:45 IST
Boehringer Ingelheim’s blockbuster diabetes drug goes off patent today—Will it lower treatment costs in India? Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure. March 11, 2025 10:51 IST
Cheapest pharma stocks in India Pharma stocks are down, but is this a golden buying opportunity? With India’s booming sector and low P/E stocks in… March 3, 2025 06:00 IST
How will Trump’s tariff threat on pharmaceuticals impact Indian drugmakers? Dr Reddy’s reacts Earlier this month, the US President said that he intends to impose a “25% or higher” levies on semiconductors and… February 25, 2025 13:01 IST
Pharma stocks are down as much as 10%. Read to know why… Pharma stocks plummet up to 10% amid looming US tariffs. Discover the impact! February 19, 2025 10:10 IST
Jefferies, Nuvama cut target price for Dr Reddy’s. 3 thing to know… Dr Reddy’s share prices dropped today as brokerages cut targets due to weak US and India performance. Explore the financial… January 24, 2025 09:17 IST
Q3FY25: Dr. Reddy’s to focus on continued CapEx investment, R&D and increasing capacity of existing portfolio The Hyderabad-based drug major had reported a profit of Rs 1,379 crore for the October-December period of last fiscal. Revenue… January 23, 2025 19:27 IST
Dr Reddy’s shares jump over 4 per cent on upgrade by Nomura The underperformance persists despite a 22.6% earnings compounded annual growth rate (CAGR) expected between FY20 and FY25F and upward revisions… December 19, 2024 21:07 IST
Toripalimab to fortify Dr. Reddy’s oncology portfolio in India In 2023, Dr. Reddy’s entered into a licensing and commercialization agreement with Shanghai Junshi Biosciences for toripalimab. December 12, 2024 10:29 IST
Dr. Reddy’s launches first immuno-oncology drug to treat rare form of head and neck cancer in India Nasopharyngeal carcinoma (NPC) is a rare, aggressive form of head and neck cancer that originates in the nasopharynx, the upper… November 28, 2024 10:47 IST
Dr Reddy’s gets Rs 27 lakh penalty from Mexican drug regulator Additionally, the fine was imposed due to an error in the date of the invoice and also in the name… November 14, 2024 17:28 IST
Dr. Reddy’s launches first-in-class drug to treat chronic constipation in India Around 12 percent of the population in India suffers from symptoms of constipation, heavily impacting their quality of life, the… October 28, 2024 17:14 IST
Aurigene Oncology reports positive outcomes of Phase 1 trial for CAR-T cell therapy in India According to the company’s press statement, it is India’s first trial for a novel autologous BCMA directed CAR-T cell therapy… October 8, 2024 16:35 IST
Dr. Reddy’s enters into licensing agreement with Gilead Sciences for HIV drug Additionally, Lenacapavir is currently under investigation for the prevention of HIV (PrEP) which is yet to be approved globally. October 3, 2024 11:54 IST
Meta CEO Mark Zuckerberg’s highest-paid employee Alexandr Wang says the next Bill Gates is a 13-year-old ‘vibe coder’: Here’s why
Zoho founder Sridhar Vembu to Google CEO Sundar Pichai: Why top tech leaders are talking about rise of Vibe Coding
Inside Sridhar Vembu’s simple Tamil Nadu home: ZOHO founder proves luxury isn’t always concrete and glass
11 Photos From Times Square to New Delhi and Burj Khalifa: How the world welcomed 2026 – In images 1 week agoJanuary 1, 2026